CN112608251A - Refining process of R-3-amino n-butanol - Google Patents

Refining process of R-3-amino n-butanol Download PDF

Info

Publication number
CN112608251A
CN112608251A CN202011493447.9A CN202011493447A CN112608251A CN 112608251 A CN112608251 A CN 112608251A CN 202011493447 A CN202011493447 A CN 202011493447A CN 112608251 A CN112608251 A CN 112608251A
Authority
CN
China
Prior art keywords
butanol
amino
refining process
temperature
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011493447.9A
Other languages
Chinese (zh)
Inventor
张�荣
吴德全
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yancheng Desano Pharmaceutical Co ltd
Original Assignee
Yancheng Desano Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yancheng Desano Pharmaceutical Co ltd filed Critical Yancheng Desano Pharmaceutical Co ltd
Priority to CN202011493447.9A priority Critical patent/CN112608251A/en
Publication of CN112608251A publication Critical patent/CN112608251A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/08Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00Asymmetric syntheses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41Preparation of salts of carboxylic acids
    • C07C51/412Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/487Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a refining process of R-3-amino n-butanol, belonging to the technical field of organic chemical industry. The R-3-amino n-butanol refining process includes oximation reaction of 4-hydroxy-2-butanone and hydroxylamine hydrochloride, hydrogenation of oximation product, addition of L-malic acid to form split salt, refining with anhydrous alcohol and dissociation to obtain high optical purity R-3-amino n-butanol. The refining process has low cost and environmental protection, and is more beneficial to industrial production.

Description

Refining process of R-3-amino n-butanol
Technical Field
The invention belongs to the technical field of organic chemical industry, and particularly relates to a refining process of R-3-amino n-butanol.
Background
The R-3-aminobutanol with optical activity is a key intermediate of a plurality of chiral drugs, such as antitumor drugs 4-methyl cyclophosphamide, beta-lactam, anti-AIDS drugs dorzolavir and the like. Compared with the existing anti-AIDS medicaments, the doramevir serving as an anti-AIDS integrase inhibitor has improved safety, does not need to be combined with medicament promoters, and has very strong medicament resistance. As a key intermediate of the chiral six-membered ring of the doriravir, the optical purity and the price of the R-3-aminobutanol have important influence on the quality and the production cost of the doriravir.
At present, the production of R-3-aminobutanol is mainly carried out by a chemical synthesis method, one method is to obtain chirally pure 3-aminobutanol by adopting a kinetic resolution method, but the chemical resolution method has the defects of low yield, high consumption of a resolving agent, harsh reaction conditions and the like. The other method is to use chiral compound as the starting material and obtain chirally pure 3-amino n-butanol through multi-step reaction of D-alanine or R-phenylethylamine.
Disclosure of Invention
Aiming at the defects of the prior art, the invention aims to provide a refining process of R-3-amino n-butanol.
In order to achieve the above purpose, the solution of the invention is:
a refining process of R-3-amino n-butanol comprises the following steps:
step 1, reacting 4-hydroxy-2-butanone with hydroxylamine hydrochloride under alkaline condition to obtain oxime compound
Figure BDA0002841363380000021
Step 2, in the presence of Raney nickel, the oxime compound obtained in the step 1 is hydrogenated, so that hydride is obtained
Figure BDA0002841363380000022
Step 3, adding L-malic acid into hydride to form a split salt, refining the split salt by absolute ethyl alcohol, and dissociating to obtain R-3-amino n-butanol
Figure BDA0002841363380000023
Further, the reaction temperature in step 1 is 5-10 ℃.
Further, the reaction temperature in step 2 was 30 ℃.
Further, the addition of L-malic acid to the hydride in step 3 was followed by stirring at 20 ℃ to form a resolved salt.
After the scheme is adopted, the R-3-amino n-butanol refining process firstly adopts 4-hydroxy-2-butanone and hydroxylamine hydrochloride to carry out oximation reaction, then carries out hydrogenation on oximation products, then adds L-malic acid to form split salt, and then carries out refining and dissociation by using absolute ethyl alcohol to obtain the R-3-amino n-butanol with high optical purity. The refining process has low cost and environmental protection, and is more beneficial to industrial production.
Detailed Description
The present invention is described in further detail below with reference to specific examples, but the present invention should not be construed as being limited thereto. Modifications or substitutions to methods, procedures, or conditions of the invention may be made without departing from the spirit and scope of the invention. The experimental methods and reagents of the formulations not specified in the examples are in accordance with the conventional conditions in the art.
Example 1
The R-3-amino n-butanol refining process of the invention comprises the following reaction processes:
Figure BDA0002841363380000031
the specific process is as follows:
step 1: oximation reaction
Figure BDA0002841363380000032
The feeding ratio is as follows:
Figure BDA0002841363380000033
the process flow is as follows:
1. adding 4-hydroxy-2-butanone, 95% ethanol and hydroxylamine hydrochloride into a 500 ml four-mouth bottle, stirring and dissolving, and cooling to 5 ℃ in ice water bath.
2. Adding 40% sodium hydroxide solution into the dropping funnel, dropping alkali liquor when the temperature of the reaction flask is reduced to 5 ℃, controlling the temperature of the reaction flask between 5 and 10 ℃, and dropping for 1 to 2 hours.
3. After dropping, the reaction is carried out for 4 hours at the temperature of 5-10 ℃, the filtration is carried out, and the mixed solution of ethanol and water is distilled off under reduced pressure at the temperature of 50 ℃.
4. When the distillate is very little, adding 20 ml of absolute ethyl alcohol and distilling once (removing water), at this time, some salt is separated out, adding 50 ml of absolute ethyl alcohol and shaking up, filtering to remove salt, and distilling the filtrate to be thick.
Steaming at 5.50 ℃ until the weight is not reduced basically, 30 g of pale yellow viscous oil is obtained, and the gas phase purity is 89.7%.
Step 2, hydrogenation reaction
Figure BDA0002841363380000041
The feeding ratio is as follows:
Figure BDA0002841363380000042
the process flow is as follows:
1. a250 ml autoclave was charged with an oximate and anhydrous ethanol, the contents of which were about 15 g of Raney nickel, and the autoclave was charged and then the atmosphere in the autoclave was replaced with argon under reduced pressure three times.
2. Introducing hydrogen into the autoclave, replacing argon in the autoclave for three times under the condition of keeping the pressure of 0.5M, increasing the pressure to 0.5M for reaction, keeping the temperature of the autoclave at 30 ℃, reacting under the condition of stirring speed of 30 revolutions, and stopping the reaction when the pressure is not changed greatly, wherein the reaction time is about 12 hours.
3. And after the reaction is finished, releasing the pressure to normal pressure, replacing the argon environment, opening the hydrogenation kettle, and performing suction filtration on the hydrogenated liquid to obtain a light yellow hydrogenated material.
The solvent in the hydrogenate was evaporated at 4.40 deg.C (water must be evaporated) and taken up once in the dry state with 10 ml of absolute ethanol to give 26 g of oil with a gas phase purity of 88%.
Step 3, resolution and dissociation
Figure BDA0002841363380000051
The feeding ratio is as follows:
Figure BDA0002841363380000052
the process flow is as follows:
salt-forming refining of chiral acid
1. Adding 250 ml of absolute ethyl alcohol into the hydrogenated liquid, if salt precipitation exists, carrying out suction filtration on a small amount of nickel powder, covering a funnel with a small amount of 2 g of diatomite, cooling the obtained filtrate by using ice water to 5-10 ℃, adding 75 g of L-malic acid 5 times in 20 minutes, stirring in the ice water to completely dissolve the solid L-malic acid, stirring for half an hour at room temperature, adding 0.1 g of splitting salt seed crystal, stirring for 10 hours at 20 ℃ for crystallization, and precipitating a large amount of white solid in about 1-2 hours.
2. Cooling to about 5-10 ℃ by using ice bath, preserving the heat for 1 hour, and performing suction filtration to obtain the split salt. Chiral purity 84.95%.
3. Splitting salt I, adding the split salt I into a single-mouth bottle, adding 200 ml of absolute ethyl alcohol, heating to 50-60 ℃, heating to dissolve, reducing the temperature to 35-40 ℃ for 1 hour, adding 0.1 g of seed crystal, stirring for 2 hours under heat preservation, reducing the temperature to 20-25 ℃ for 1 hour, preserving the heat for 1 hour, reducing the temperature to 5-10 ℃, stirring for 1 hour under heat preservation, and filtering to obtain a refined product with chiral purity of 96.29%.
4. Splitting the salt II, adding the first refined product into a single-mouth bottle, adding 150 ml of absolute ethyl alcohol, heating to raise the temperature to dissolve the first refined product (about 60-70 ℃), reducing the temperature to 35-40 ℃ within 1 hour, adding 0.1 g of seed crystal, keeping the temperature and stirring for 2 hours, reducing the temperature to 20-25 ℃ within 1 hour, keeping the temperature for 1 hour, reducing the temperature to 5-10 ℃, keeping the temperature and stirring for 1 hour, and performing suction filtration to obtain the second refined product with the chiral purity of 99.11%.
5. Splitting the salt III essence, adding the second refined product into a single-mouth bottle, adding 150 ml of absolute ethyl alcohol, heating to raise the temperature to dissolve the salt III essence (about 70 ℃), reducing the temperature to 40 ℃ within 1 hour, adding 0.1 g of seed crystal, keeping the temperature and stirring for 2 hours, reducing the temperature to 20-25 ℃ within 1 hour, keeping the temperature for 1 hour, reducing the temperature to 5-10 ℃, keeping the temperature and stirring for 1 hour, and performing suction filtration to obtain the third refined product with the chiral purity of 99.85%. Enantiomer 0.15%.
6. Splitting the salt four essence, adding the three essence into a single-mouth bottle, adding 150 ml of absolute ethyl alcohol, heating to raise the temperature to dissolve the three essence clearly (about 75 ℃), reducing the temperature to 45 ℃ within 1 hour, adding 0.1 g of seed crystal, keeping the temperature and stirring for 2 hours, reducing the temperature to 20-25 ℃ within 1 hour, keeping the temperature for 1 hour, reducing the temperature to 5-10 ℃, keeping the temperature and stirring for 1 hour, and performing suction filtration to obtain the three essence with the chiral purity of 99.96%. Enantiomer 0.04%. Vacuum drying at 45 ℃ gave 35 g of the resolved salt.
(II) dissociation
1. Adding 69 g of 20% sodium hydroxide solution into a single-mouth bottle, and adding 35 g of resolving salt (without heat release) in three batches at 10-20 ℃ in a water bath under stirring for about 10 min;
2. stirring at 20 + -5 deg.C until the solid is substantially dissolved (about half an hour), leaving a very small amount of solid undissolved;
3. adding 50 ml of isopropanol, stirring for 10 minutes, separating liquid, standing for 20 minutes, basically separating, collecting an upper isopropanol layer, and separating a lower layer into the just single-mouth bottle;
4. adding 50 ml of isopropanol into the single-mouth bottle, stirring for 10 minutes, separating, standing for 20 minutes, layering after a clear interface, and combining isopropanol layers; no product was detected on the water ply layer.
Concentrating an isopropanol layer at 5.40 degrees (no material is brought out during isopropanol distillation), adding 10 ml of isopropanol with primary water after concentrating and drying, concentrating for half an hour by using a material water pump, pumping out residual water, and transferring to an oil pump for reduced pressure distillation after the water content is measured to be less than 1%;
6. distilling the liquid to be distilled under high vacuum of an oil pump (the vacuum degree of the oil pump is 60pa), firstly, at room temperature, not starting condensation circulation, pulling away a small amount of residual solvent and a small amount of water, after 20 minutes, starting condensed water and then heating. Slowly heating to 90 ℃, condensing the effluent at the temperature of minus 15 ℃ of an ice maker, distilling to obtain the distillate at the temperature of 60 ℃, and obtaining the colorless product of 12.9g (the molar yield of the free distillation in the step is 92.3%).
The detection shows that the GC purity of the obtained product is more than 99 percent, the maximum impurity is less than 0.5 percent, the water content is less than 1 percent, and the chirality is 99.90 percent.
The R-3-amino n-butanol refining process includes oximation reaction of 4-hydroxy-2-butanone and hydroxylamine hydrochloride, hydrogenation of oximation product, addition of L-malic acid to form split salt, refining with anhydrous alcohol and dissociation to obtain high optical purity R-3-amino n-butanol. The refining process has low cost and environmental protection, and is more beneficial to industrial production.
The above embodiments are only for illustrating the technical idea of the present invention, and the protection scope of the present invention is not limited thereby, and any modifications made on the basis of the technical scheme according to the technical idea of the present invention fall within the protection scope of the present invention.

Claims (4)

1. A refining process of R-3-amino n-butanol is characterized by comprising the following steps:
step 1, reacting 4-hydroxy-2-butanone with hydroxylamine hydrochloride under alkaline condition to obtain oxime compound
Figure FDA0002841363370000011
Step 2, in the presence of Raney nickel, the oxime compound obtained in the step 1 is hydrogenated, so that hydride is obtained
Figure FDA0002841363370000012
Step 3, adding L-malic acid into hydride to form a split salt, refining the split salt by absolute ethyl alcohol, and dissociating to obtain R-3-amino n-butanol
Figure FDA0002841363370000013
2. The refining process of claim 1, wherein: in the step 1, the reaction temperature is 5-10 ℃.
3. The refining process of claim 1, wherein: in the step 2, the reaction temperature is 30 ℃.
4. The refining process of claim 1, wherein: in the step 3, L-malic acid is added into hydride and reacts at 20 ℃ to form a resolved salt.
CN202011493447.9A 2020-12-17 2020-12-17 Refining process of R-3-amino n-butanol Pending CN112608251A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011493447.9A CN112608251A (en) 2020-12-17 2020-12-17 Refining process of R-3-amino n-butanol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011493447.9A CN112608251A (en) 2020-12-17 2020-12-17 Refining process of R-3-amino n-butanol

Publications (1)

Publication Number Publication Date
CN112608251A true CN112608251A (en) 2021-04-06

Family

ID=75239997

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011493447.9A Pending CN112608251A (en) 2020-12-17 2020-12-17 Refining process of R-3-amino n-butanol

Country Status (1)

Country Link
CN (1) CN112608251A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4330484A (en) * 1979-08-22 1982-05-18 Basf Aktiengesellschaft Diastereomeric salts of malic acid and 2-aminobutanol, and process for the resolution of rademis maic acid
US20160108058A1 (en) * 2013-02-19 2016-04-21 Aurobindo Pharma Ltd. An improved process for the preparation of Dolutegravir
CN107793320A (en) * 2016-09-05 2018-03-13 上海迪赛诺药业股份有限公司 The method that chiral resolution prepares the butanol of 3 amino of single configuration 1
CN107805205A (en) * 2017-11-10 2018-03-16 浙江新和成股份有限公司 A kind of preparation method of (R) 3 amino butanol
CN109608344A (en) * 2018-12-28 2019-04-12 凯瑞斯德生化(苏州)有限公司 A kind of preparation method of (R) -3- amino butanol

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4330484A (en) * 1979-08-22 1982-05-18 Basf Aktiengesellschaft Diastereomeric salts of malic acid and 2-aminobutanol, and process for the resolution of rademis maic acid
US20160108058A1 (en) * 2013-02-19 2016-04-21 Aurobindo Pharma Ltd. An improved process for the preparation of Dolutegravir
CN107793320A (en) * 2016-09-05 2018-03-13 上海迪赛诺药业股份有限公司 The method that chiral resolution prepares the butanol of 3 amino of single configuration 1
CN107805205A (en) * 2017-11-10 2018-03-16 浙江新和成股份有限公司 A kind of preparation method of (R) 3 amino butanol
CN109608344A (en) * 2018-12-28 2019-04-12 凯瑞斯德生化(苏州)有限公司 A kind of preparation method of (R) -3- amino butanol

Similar Documents

Publication Publication Date Title
US11008279B2 (en) Method for purifying 1,5-pentanediamine and the 1,5-pentanediamine prepared thereby
CN110590757A (en) Preparation method of posaconazole
CN111153765B (en) Vitamin K with different cis-trans isomer ratios1Preparation method of halogenated plant alcohol as intermediate thereof
TW201429924A (en) Production method of refined amine compound
CN107311861B (en) 4-methoxy ethyl acetoacetate and synthetic method thereof
CN107513023B (en) Preparation method of terbutaline sulfate
CN112608243A (en) Synthesis method of trans-3-aminobutanol
CN112608251A (en) Refining process of R-3-amino n-butanol
CN107935971B (en) Preparation method of (S) -3-hydroxytetrahydrofuran
CN108752217B (en) Synthesis method of dolutegravir key intermediate 2, 4-difluorobenzylamine
WO2014034957A1 (en) Method for producing (r)-1,1,3-trimethyl-4-aminoindane
CN115368318A (en) Synthetic method and application of vortioxetine
CN109627174B (en) Preparation method of chiral sertraline hydrochloride
CN111675671A (en) Preparation method of venlafaxine impurity E
CN108484484B (en) Preparation method of 2-oxo-3-ethyl piperidinecarboxylate
CN113735764A (en) Method for recovering 2-cyano-3-chloro-5-trifluoromethylpyridine rectifying still residue
CN112479824A (en) Method for recovering crystallization mother liquor in production process of 4-chloro-3, 5-dimethylphenol
CN109879780B (en) Preparation method of (2-methylamine-ethyl) -tert-butyl carbamate
CN112830879A (en) Preparation method of cinacalcet hydrochloride
CN110668958A (en) Method for preparing (R) -3-aminobutanol
CN113563318A (en) Synthesis method of engagliflozin
CN115594578B (en) Method for purifying erucic acid by adopting steam stripping mode
CN115466255B (en) Tropine and synthetic method thereof
CN112745262B (en) Preparation method of brexpiprazole intermediate 7-hydroxy-1H-quinoline-2-ketone
CN100469759C (en) Toremifene crystallization method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20210406

RJ01 Rejection of invention patent application after publication